|
1
|
Gray-Schopfer V, Wellbrock C and Marais R:
Melanoma biology and new targeted therapy. Nature. 445:851–857.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arozarena I, Sanchez-Laorden B, Packer L,
Hidalgo-Carcedo C, Hayward R, Viros A, Sahai E and Marais R:
Oncogenic BRAF induces melanoma cell invasion by downregulating the
cGMP-specific phosphodiesterase PDE5A. Cancer Cell. 19:45–57. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cummins DL, Cummins JM, Pantle H,
Silverman MA, Leonard AL and Chanmugam A: Cutaneous malignant
melanoma. Mayo Clin Proc. 81:500–507. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang L, Zhang W, Su B and Yu B: Long
noncoding RNA HOTAIR is associated with motility, invasion, and
metastatic potential of metastatic melanoma. BioMed Res Int.
2013:251098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Muers M: RNA: genome-wide views of long
non-coding RNAs. Nat Rev Genet. 12:742–743. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shore AN, Herschkowitz JI and Rosen JM:
Noncoding RNAs involved in mammary gland development and
tumorigenesis: there’s a long way to go. J Mammary Gland Biol
Neoplasia. 17:43–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schmidt K, Joyce CE, Buquicchio F, Brown
A, Ritz J, Distel RJ, Yoon CH and Novina CD: The lncRNA SLNCR1
mediates melanoma invasion through a conserved SRA1-like region.
Cell Reports. 15:2025–2037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Flockhart RJ, Webster DE, Qu K,
Mascarenhas N, Kovalski J, Kretz M and Khavari PA:
BRAFV600E remodels the melanocyte transcriptome and
induces BANCR to regulate melanoma cell migration. Genome Res.
22:1006–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Colombo T, Farina L, Macino G and Paci P:
PVT1: a rising star among oncogenic long noncoding RNAs. BioMed Res
Int. 2015:3042082015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guan Y, Kuo WL, Stilwell JL, Takano H,
Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, Santos JL, et al:
Amplification of PVT1 contributes to the pathophysiology of ovarian
and breast cancer. Clin Cancer Res. 13:5745–5755. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barsotti AM, Beckerman R, Laptenko O,
Huppi K, Caplen NJ and Prives C: p53-dependent induction of PVT1
and miR-1204. J Biol Chem. 287:2509–2519. 2012. View Article : Google Scholar :
|
|
14
|
Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS
and Feng XJ: Increased expression of the lncRNA PVT1 promotes
tumori-genesis in non-small cell lung cancer. Int J Clin Exp
Pathol. 7:6929–6935. 2014.
|
|
15
|
Zhou Q, Chen J, Feng J and Wang J: Long
noncoding RNA PVT1 modulates thyroid cancer cell proliferation by
recruiting EZH2 and regulating thyroid-stimulating hormone receptor
(TSHR). Tumour Biol. 37:3105–3113. 2016. View Article : Google Scholar
|
|
16
|
Franken NAP, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
18
|
Biddle A and Mackenzie IC: Cancer stem
cells and EMT in carcinoma. Cancer Metastasis Rev. 31:285–293.
2012. View Article : Google Scholar
|
|
19
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu Y, Brenn T, Brown ER, Doherty V and
Melton DW: Differential expression of microRNAs during melanoma
progression: miR-200c, miR-205 and miR-211 are downregulated in
melanoma and act as tumour suppressors. Br J Cancer. 106:553–561.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chase A and Cross NC: Aberrations of EZH2
in cancer. Clin Cancer Res. 17:2613–2618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen H, Xu J, Hong J, Tang R, Zhang X and
Fang JY: Long noncoding RNA profiles identify five distinct
molecular subtypes of colorectal cancer with clinical relevance.
Mol Oncol. 8:1393–1403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang C, Yu W, Wang Q, Cui H, Wang Y,
Zhang L, Han F and Huang T: Increased expression of the lncRNA PVT1
is associated with poor prognosis in pancreatic cancer patients.
Minerva Med. 106:143–149. 2015.PubMed/NCBI
|
|
24
|
Takahashi Y, Sawada G, Kurashige J, Uchi
R, Matsumura T, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, et
al: Amplification of PVT-1 is involved in poor prognosis via
apoptosis inhibition in colorectal cancers. Br J Cancer.
110:164–171. 2014. View Article : Google Scholar :
|
|
25
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX,
Ye C, Yang N, Zhou WP, Li WL, Li W, et al: Oncofetal long noncoding
RNA PVT1 promotes proliferation and stem cell-like property of
hepatocellular carcinoma cells by stabilizing NOP2. Hepatology.
60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kong R, Zhang EB, Yin DD, You LH, Xu TP,
Chen WM, Xia R, Wan L, Sun M, Wang ZX, et al: Long noncoding RNA
PVT1 indicates a poor prognosis of gastric cancer and promotes cell
proliferation through epigenetically regulating p15 and p16. Mol
Cancer. 14:822015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gautschi O, Ratschiller D, Gugger M,
Betticher DC and Heighway J: Cyclin D1 in non-small cell lung
cancer: a key driver of malignant transformation. Lung Cancer.
55:1–14. 2007. View Article : Google Scholar
|
|
28
|
Li Z, Tian T, Lv F, Chang Y, Wang X, Zhang
L, Li X, Li L, Ma W, Wu J, et al: Six1 promotes proliferation of
pancreatic cancer cells via upregulation of cyclin D1 expression.
PLoS One. 8:e592032013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Khoo ML, Beasley NJ, Ezzat S, Freeman JL
and Asa SL: Overexpression of cyclin D1 and underexpression of p27
predict lymph node metastases in papillary thyroid carcinoma. J
Clin Endocrinol Metab. 87:1814–1818. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li G, Satyamoorthy K and Herlyn M:
N-cadherin-mediated intercellular interactions promote survival and
migration of melanoma cells. Cancer Res. 61:3819–3825.
2001.PubMed/NCBI
|
|
32
|
Hsu MY, Meier FE, Nesbit M, Hsu JY, Van
Belle P, Elder DE and Herlyn M: E-cadherin expression in melanoma
cells restores keratinocyte-mediated growth control and
down-regulates expression of invasion-related adhesion receptors.
Am J Pathol. 156:1515–1525. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Slagle BL, Zhou YZ, Birchmeier W and
Scorsone KA: Deletion of the E-cadherin gene in hepatitis B
virus-positive Chinese hepatocellular carcinomas. Hepatology.
18:757–762. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li M, Zhang B, Sun B, Wang X, Ban X, Sun
T, Liu Z and Zhao X: A novel function for vimentin: the potential
biomarker for predicting melanoma hematogenous metastasis. J Exp
Clin Cancer Res. 29:1092010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
du Rieu MC, Torrisani J, Selves J, Al
Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA,
Carrère N, Buscail L, et al: MicroRNA-21 is induced early in
pancreatic ductal adenocarcinoma precursor lesions. Clin Chem.
56:603–612. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tao T, Liu D, Liu C, Xu B, Chen S, Yin Y,
Ang L, Huang Y, Zhang X and Chen M: Autoregulatory feedback loop of
EZH2/miR-200c/E2F3 as a driving force for prostate cancer
development. Biochim Biophys Acta. 1839:858–865. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ning X, Shi Z, Liu X, Zhang A, Han L,
Jiang K, Kang C and Zhang Q: DNMT1 and EZH2 mediated methylation
silences the microRNA-200b/a/429 gene and promotes tumor
progression. Cancer Lett. 359:198–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
